Spots Global Cancer Trial Database for recurrent carcinoma of unknown primary
Every month we try and update this database with for recurrent carcinoma of unknown primary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum | NCT00005860 | Cancer | floxuridine leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors | NCT00004922 | Carcinoma of Un... Neuroendocrine ... Neuroendocrine ... | irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors | NCT00004922 | Carcinoma of Un... Neuroendocrine ... Neuroendocrine ... | irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | NCT00004005 | Carcinoma of Un... Colorectal Canc... Unspecified Adu... Unspecified Chi... | fluorouracil irinotecan hydr... leucovorin calc... conventional su... radiation thera... | - 24 Years | St. Jude Children's Research Hospital | |
Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer | NCT00002507 | Carcinoma of Un... Head and Neck C... | mitomycin C porfiromycin brachytherapy radiation thera... | 20 Years - 80 Years | Yale University | |
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00003548 | Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | NCT00006361 | Carcinoma of Un... Head and Neck C... Non-melanomatou... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors | NCT00004922 | Carcinoma of Un... Neuroendocrine ... Neuroendocrine ... | irinotecan hydr... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | NCT00004005 | Carcinoma of Un... Colorectal Canc... Unspecified Adu... Unspecified Chi... | fluorouracil irinotecan hydr... leucovorin calc... conventional su... radiation thera... | - 24 Years | St. Jude Children's Research Hospital |